Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

A phase II study (PRIMMO) of patients with pretreated persistent/recurrent/metastatic cervical or endometrial cancer is presented. Patients received an immunomodulatory five-drug cocktail (IDC) consisting of low-dose cyclophosphamide, aspirin, lansoprazole, vitamin D, and curcumin starting 2 weeks b...

Descripción completa

Detalles Bibliográficos
Autores principales: De Jaeghere, Emiel A., Tuyaerts, Sandra, Van Nuffel, An M. T., Belmans, Ann, Bogaerts, Kris, Baiden-Amissah, Regina, Lippens, Lien, Vuylsteke, Peter, Henry, Stéphanie, Trinh, Xuan Bich, van Dam, Peter A., Aspeslagh, Sandrine, De Caluwé, Alex, Naert, Eline, Lambrechts, Diether, Hendrix, An, De Wever, Olivier, Van de Vijver, Koen K., Amant, Frédéric, Vandecasteele, Katrien, Denys, Hannelore G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870976/
https://www.ncbi.nlm.nih.gov/pubmed/35960332
http://dx.doi.org/10.1007/s00262-022-03253-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870976/
https://www.ncbi.nlm.nih.gov/pubmed/35960332
http://dx.doi.org/10.1007/s00262-022-03253-x

Ejemplares similares